- Home
- LENZ vs ELME Comparison
LENZ vs ELME Comparison
Compare LENZ & ELME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LENZ
- ELME
- Stock Information
- Founded
- LENZ 2019
- ELME 1960
- Country
- LENZ United States
- ELME United States
- Employees
- LENZ N/A
- ELME N/A
- Industry
- LENZ Medicinal Chemicals and Botanical Products
- ELME Real Estate Investment Trusts
- Sector
- LENZ Health Care
- ELME Real Estate
- Exchange
- LENZ Nasdaq
- ELME Nasdaq
- Market Cap
- LENZ 1.2B
- ELME 1.4B
- IPO Year
- LENZ 2021
- ELME N/A
- Fundamental
- Price
- LENZ $48.74
- ELME $16.79
- Analyst Decision
- LENZ Strong Buy
- ELME Hold
- Analyst Count
- LENZ 4
- ELME 5
- Target Price
- LENZ $49.75
- ELME $14.25
- AVG Volume (30 Days)
- LENZ 406.2K
- ELME 985.3K
- Earning Date
- LENZ 11-05-2025
- ELME 11-03-2025
- Dividend Yield
- LENZ N/A
- ELME 4.29%
- EPS Growth
- LENZ N/A
- ELME N/A
- EPS
- LENZ N/A
- ELME N/A
- Revenue
- LENZ $5,000,000.00
- ELME $245,911,000.00
- Revenue This Year
- LENZ N/A
- ELME N/A
- Revenue Next Year
- LENZ $285.73
- ELME $8.14
- P/E Ratio
- LENZ N/A
- ELME N/A
- Revenue Growth
- LENZ N/A
- ELME 4.59
- 52 Week Low
- LENZ $16.54
- ELME $13.95
- 52 Week High
- LENZ $50.40
- ELME $18.08
- Technical
- Relative Strength Index (RSI)
- LENZ 70.59
- ELME 48.17
- Support Level
- LENZ $39.51
- ELME $16.67
- Resistance Level
- LENZ $50.40
- ELME $16.93
- Average True Range (ATR)
- LENZ 2.17
- ELME 0.16
- MACD
- LENZ 0.66
- ELME -0.03
- Stochastic Oscillator
- LENZ 84.76
- ELME 30.26
About LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.
About ELME Elme Communities
Elme Communities is a real estate investment trust engaged in owning and operating properties in the greater Washington DC metropolitan area. The company's real estate portfolio is comprised of office, retail, and multifamily properties located near transportation nodes. Washington REIT derives nearly all of its income in the form of rental revenue from tenants organized into long-term leases. The company's office assets contribute the majority of this income, while the rest is split fairly evenly between its retail and multifamily locations. Washington REIT's tenants are banking, consulting, law, and financial services firms.